story of the week
MS Therapies Differentially Impact SARS-CoV-2 Vaccine–Induced Antibody and T-Cell Immunity and Function
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JCI insight
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Multiple sclerosis therapies differentially impact SARS-CoV-2 vaccine-induced antibody and T cell immunity and function
JCI Insight 2022 Jan 14;[EPub Ahead of Print], JJ Sabatino, K Mittl, WM Rowles, K McPolin, JV Rajan, MT Laurie, CR Zamecnik, R Dandekar, BD Alvarenga, RP Loudermilk, C Gerungan, CM Spencer, SA Sagan, DG Augusto, JR Alexander, JL DeRisi, JA Hollenbach, MR Wilson, SS Zamvil, R BoveFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.